Itraconazole responsive tinea capitis in an HIV-infected child.
Tinea capitis has not been reported to be a prevalent or serious affliction in pediatric patients infected with the human immunodeficiency virus (HIV). We report tinea capitis due to Microsporum canis in a boy infected with HIV. After failing conventional therapy, he was treated successfully with a four-week course of itraconazole. His immunologic status improved during therapy. The possible relationship of this response to the ultimate resolution of disease is discussed.
Smith
R L
RL
Virginia Mason Clinic, Seattle, Washington, USA.
Levy
M L
ML
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016516:CD4-CD8 Ratio / Q000187:drug effects; D002648:Child; D015658:HIV Infections / Q000276:immunology; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008864:Microsporum / Q000302:isolation & purification; D014006:Tinea Capitis / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome
D000935:Antifungal Agents; D017964:Itraconazole